암환자 등록 소프트웨어 시장 : 유형별, 데이터베이스 유형별, 기능별, 배포별, 최종 사용자별 - 세계 예측(2025-2030년)

The Cancer Registry Software Market was valued at USD 87.62 million in 2023, expected to reach USD 98.04 million in 2024, and is projected to grow at a CAGR of 11.98%, to USD 193.47 million by 2030.

Cancer Registry Software is a specialized data system used for the collection, storage, management, and analysis of cancer patient data. It is crucial for tracking trends, guiding policy-making, and improving cancer treatment outcomes. Its scope encompasses healthcare facilities such as hospitals, research centers, and government agencies. The necessity of cancer registry software lies in its ability to enable comprehensive epidemiological studies, identify risk factors, and evaluate the efficacy of treatments, ultimately contributing to enhanced healthcare strategies. Applications of this software include patient follow-up, resource allocation, and survival rate analysis, which benefit healthcare providers, researchers, and policymakers. The end-use scope is broad, ranging from aiding clinical research and advancing public health initiatives to supporting healthcare providers in the management of patient data and improving treatment protocols.

Market growth is significantly influenced by the rising incidence of cancer globally, increasing demand for efficient data management tools, and advancements in healthcare IT infrastructure. The latest potential opportunities include integration of AI and machine learning technologies to enhance data accuracy and predictive analytics capabilities. To capitalize on these opportunities, stakeholders should focus on partnerships and collaborations with tech companies, as well as invest in user-friendly and secure software solutions. However, challenges such as data privacy concerns, high implementation costs, and the need for skilled personnel may hinder market growth. Stringent regulations and interoperability issues are also significant constraints.

Innovative areas for growth include the development of cloud-based solutions for easy access and collaboration, personalized medicine through data-driven insights, and the integration of registry data with electronic health records (EHR) for more comprehensive patient profiles. The market is dynamic and competitive, characterized by technological advancements and a focus on improving user experience. Companies should prioritize research into robust cybersecurity measures and training programs to address personnel shortages and regulatory compliance, ensuring that they remain competitive while catering to the evolving needs of the healthcare sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cancer Registry Software Market

The Cancer Registry Software Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Surge in prevalences of cancer across the world
  • Growing adoption of electronic health records
  • Increasing demand for cloud-based cancer patients registry software solutions
• Market Restraints
  • Lack of awareness about cancer registry software among end-users
• Market Opportunities
  • Surge in the government initiatives for development of cancer registry software
  • Technological developments in the cancer registry software solutions
• Market Challenges
  • Concern over security and privacy of data

Porter's Five Forces: A Strategic Tool for Navigating the Cancer Registry Software Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cancer Registry Software Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cancer Registry Software Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cancer Registry Software Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cancer Registry Software Market

A detailed market share analysis in the Cancer Registry Software Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cancer Registry Software Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cancer Registry Software Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cancer Registry Software Market

A strategic analysis of the Cancer Registry Software Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cancer Registry Software Market, highlighting leading vendors and their innovative profiles. These include C/Net Solutions, Conduent, Inc., Dacima Software Inc., Elekta AB, ERS, Inc., IBM Corporation, Inspirata, Inc., IQVIA Inc, Mckesson Corporation, NAACCR, Inc., NeuralFrame, Inc, NextPath LLC, Omega Healthcare, Onco, Inc., Ordinal Data, Inc, Q-Centrix, LLC, Rocky Mountain Cancer Data Systems, and Siemens Healthineers AG.

Market Segmentation & Coverage

This research report categorizes the Cancer Registry Software Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Integrated Software and Standalone Software.
• Based on Database Type, market is studied across Commercial Databases and Public Databases.
• Based on Functionality, market is studied across Cancer Reporting, Medical Research & Clinical Studies, Patient Care Management, and Product Outcome Evaluation.
• Based on Deployment, market is studied across On-Cloud and On-Premise.
• Based on End User, market is studied across Government Organizations & Third-Party Administrators, Hospitals & Medical Practices, Private Payers, and Research Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Surge in prevalences of cancer across the world
    • 5.1.1.2. Growing adoption of electronic health records
    • 5.1.1.3. Increasing demand for cloud-based cancer patients registry software solutions
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of awareness about cancer registry software among end-users
  • 5.1.3. Opportunities
    • 5.1.3.1. Surge in the government initiatives for development of cancer registry software
    • 5.1.3.2. Technological developments in the cancer registry software solutions
  • 5.1.4. Challenges
    • 5.1.4.1. Concern over security and privacy of data
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cancer Registry Software Market, by Type

• 6.1. Introduction
• 6.2. Integrated Software
• 6.3. Standalone Software

7. Cancer Registry Software Market, by Database Type

• 7.1. Introduction
• 7.2. Commercial Databases
• 7.3. Public Databases

8. Cancer Registry Software Market, by Functionality

• 8.1. Introduction
• 8.2. Cancer Reporting
• 8.3. Medical Research & Clinical Studies
• 8.4. Patient Care Management
• 8.5. Product Outcome Evaluation

9. Cancer Registry Software Market, by Deployment

• 9.1. Introduction
• 9.2. On-Cloud
• 9.3. On-Premise

10. Cancer Registry Software Market, by End User

• 10.1. Introduction
• 10.2. Government Organizations & Third-Party Administrators
• 10.3. Hospitals & Medical Practices
• 10.4. Private Payers
• 10.5. Research Centers

11. Americas Cancer Registry Software Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Cancer Registry Software Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Cancer Registry Software Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. C/Net Solutions
• 2. Conduent, Inc.
• 3. Dacima Software Inc.
• 4. Elekta AB
• 5. ERS, Inc.
• 6. IBM Corporation
• 7. Inspirata, Inc.
• 8. IQVIA Inc
• 9. Mckesson Corporation
• 10. NAACCR, Inc.
• 11. NeuralFrame, Inc
• 12. NextPath LLC
• 13. Omega Healthcare
• 14. Onco, Inc.
• 15. Ordinal Data, Inc
• 16. Q-Centrix, LLC
• 17. Rocky Mountain Cancer Data Systems
• 18. Siemens Healthineers AG